Alveron Pharma Announces €5M Seed Extension Financing To Accelerate Breakthrough Therapy For Intracranial HaemorrhageGrace Crocker2024-12-09T14:20:07+00:00December 9th, 2024|BioCity Nottingham, Investment|
Pioneer Group Welcomes R&D Funding Announced In Budget For Life Sciences And Planetary HealthAmy Cotterill2024-11-14T09:17:40+00:00October 30th, 2024|News|
Novo Nordisk Partners With Pioneer Group To Launch The Golden Ticket ProgrammeGrace Crocker2024-12-05T10:36:15+00:00September 19th, 2024|Accelerator, Investment, News|
NanoSyrinx Closes c. £10 Million Financing And Appoints Dr Edwin Moses As ChairmanGrace Crocker2024-11-28T14:22:38+00:00September 11th, 2024|Investment, News|
Kent Science Park & Canterbury Christ Church University Innovation ShowcaseGrace Crocker2024-09-09T15:11:58+01:00September 9th, 2024|Kent Science Park, News|
Pioneer Group Adds AI In Health Accelerator To Yearly Offering Of ProgrammesBeckie Barrett2024-11-28T13:58:22+00:00August 22nd, 2024|Accelerator, Article|
What Are The Current Life Sciences Investment Trends?Beckie Barrett2024-08-21T14:19:26+01:00August 21st, 2024|Article, Investment|
MediCity Nottingham: 4D Medicine Raises £3.4m For Unique Biomaterial PlatformGrace Crocker2024-11-28T14:22:54+00:00July 26th, 2024|Investment, MediCity Nottingham, News|
Victoria House: The Centrepiece Of London Lab SpaceBeckie Barrett2024-11-28T16:47:15+00:00July 18th, 2024|Article, Investment|
Life Science Real Estate: A New Lease Of Life For The Golden TriangleBeckie Barrett2024-11-28T16:47:32+00:00July 12th, 2024|Article, Investment, The Crown Estate|
